Reply to K.L. Campbell et al

Jennifer A Ligibel¹, Kari Bohlke¹, Catherine M Alfano¹

• ¹Jennifer A. Ligibel, MD, Dana-Farber Cancer Institute, Boston, MA; Kari Bohlke, ScD, American Society of Clinical Oncology, Alexandria, VA; and Catherine M. Alfano, PhD, Northwell Health Cancer Institute and Feinstein Institutes for Medical Research, New York, NY.